<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Brakke&#x54A8;&#x8BE2;&#x7F51;&#x7AD9;</provider_name><provider_url>https://brakkeconsulting.com/zh</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="9RbDqAiitV"&gt;&lt;a href="https://brakkeconsulting.com/zh/24031/"&gt;2015 &#x5E74; 9 &#x6708; 25 &#x65E5;&#x52A8;&#x7269;&#x5065;&#x5EB7;&#x65B0;&#x95FB;&#x4E0E;&#x6CE8;&#x91CA;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/zh/24031/embed/#?secret=9RbDqAiitV" width="600" height="338" title="&#x300A; Animal Health News &amp; Notes for September 25, 2015 &#x300B;&#x2014;Brakke Consulting Website" data-secret="9RbDqAiitV" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>printer friendly *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for September 25, 2015 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news Transaction assistance &nbsp; earnings news Neogen &nbsp; other news Bayer BioZyme Boehringer Ingelheim Ceva Cook Animal Health Gour Medical Harrisvaccines MedVet Medical &amp; Cancer Centers for Pets Merck MILA International MWI Petco PetSmart Solmic Research Tomlyn Zoetis&nbsp;&nbsp; &nbsp; ************************************ BRAKKE CONSULTING, INC. TRANSACTION ASSISTANCE When the Time Is Right Buying, selling or merging? We can help! Brakke Consulting has assisted many clients with mergers, acquisitions and divestitures. Our transaction experts can provide the insight, ability and contacts you need in the animal health, pet, veterinary and specialty chemicals markets. Please contact any of our offices for a confidential consultation. &nbsp; www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES &nbsp; &gt; Neogen Corporation announced results for the first quarter of its 2016 fiscal year ended Aug. 31. Revenues were $75 million, an 11% increase compared to the first quarter of last year. First quarter net income increased 5% to $9.3 million. Animal Safety revenues increased 10% to $40.4 million. (company press release)&nbsp; &nbsp; ************************************ COMPANY NEWS RELEASES &nbsp; &gt; Bayer Animal Health announced the approval of Claro (florfenicol, terbinafine, mometasone furoate) Otic Solution, the first single-dose therapy to treat susceptible strainsView Full Post;</description></oembed>
